Tag Archives: Ultragenyx

October, 2018

May, 2018

April, 2018

November, 2017

April, 2017

June, 2016

October, 2015

  • 30 October

    Ultragenyx and Arcturus Enter Potential $1.57 Billion RNA Collaboration

    NOVATO, Calif., Oct. 29, 2015 /PRNewswire/ — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Arcturus Therapeutics, Inc., a leading RNA medicines company, today announced that they have entered into a research collaboration and license agreement to discover …